Ramesh Mullangi Selected Research

Ramesh Mullangi Research Topics

Disease

13	Neoplasms (Cancer) 04/2021 - 04/2005
6	Rheumatoid Arthritis 11/2020 - 01/2010
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2021 - 01/2019
3	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 01/2018
2	Atherosclerosis 05/2020 - 01/2009
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020 - 11/2019
2	Obesity 01/2018 - 01/2018
2	Inflammation (Inflammations) 12/2006 - 10/2006
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2021
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2021
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2020
1	Poisoning 06/2019
1	Gram-Positive Bacterial Infections 02/2018
1	Body Weight (Weight, Body) 01/2018
1	Weight Loss (Weight Reduction) 01/2018
1	Insulin Resistance 01/2018
1	Metabolic Diseases (Metabolic Disease) 01/2018
1	Carcinogenesis 03/2017
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2017
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2017
1	Ulcer 10/2016
1	Hypoglycemia (Reactive Hypoglycemia) 05/2016
1	Weight Gain 05/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2013
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 10/2013
1	Respiratory Tract Infections (Respiratory Tract Infection) 10/2013
1	Soft Tissue Infections 10/2013
1	Osteoarthritis 01/2010
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2010
1	Myocardial Infarction 01/2009
1	Nociceptive Pain 01/2009
1	Stroke (Strokes) 01/2009
1	Acute Kidney Injury (Acute Renal Failure) 10/2007
1	Edema (Dropsy) 12/2006

Drug/Important Bio-Agent (IBA)

4	GLPG0634IBA 11/2020 - 01/2020
4	Proteins (Proteins, Gene)FDA Link 01/2018 - 10/2013
3	darolutamideIBA 01/2021 - 01/2018
3	Janus Kinase InhibitorsIBA 05/2020 - 01/2020
3	Pharmaceutical PreparationsIBA 01/2020 - 12/2006
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 04/2021 - 01/2020
2	larotrectinibIBA 12/2020 - 02/2020
2	enasidenibIBA 01/2020 - 11/2019
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2020 - 11/2019
2	Biological ProductsIBA 01/2020 - 10/2013
2	N-nitroso-N-methyltyramine (NNMT)IBA 01/2018 - 01/2018
2	1- (1- (2- amino- pyridin- 4- ylmethyl)- 1H- indol- 4- yl)- 3- (5- bromo- 2- methoxyphenyl)ureaIBA 02/2012 - 07/2011
2	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 12/2006 - 10/2006
1	sotorasibIBA 04/2021
1	idelalisibIBA 01/2021
1	tropomyosin kinaseIBA 12/2020
1	CeramidesIBA 05/2020
1	copanlisibIBA 01/2020
1	vorasidenibIBA 11/2019
1	ivosidenibIBA 11/2019
1	Fomepizole (Antizol)FDA LinkGeneric 06/2019
1	Alcohol Dehydrogenase (Alcohol Dehydrogenase (NAD+))IBA 06/2019
1	Methanol (Carbinol)IBA 06/2019
1	AntidotesIBA 06/2019
1	Antineoplastic Agents (Antineoplastics)IBA 01/2019
1	Bendamustine Hydrochloride FDA Link 01/2019
1	LipoglycopeptidesIBA 02/2018
1	nilutamide (Nilandron)FDA Link 01/2018
1	Nonsteroidal Anti-AndrogensIBA 01/2018
1	Nicotinamide N-MethyltransferaseIBA 01/2018
1	enzalutamideIBA 01/2018
1	bicalutamide (Casodex)FDA LinkGeneric 01/2018
1	apalutamideIBA 01/2018
1	Flutamide (Eulexin)FDA LinkGeneric 01/2018
1	Glucose (Dextrose)FDA LinkGeneric 01/2018
1	Insulin (Novolin)FDA Link 01/2018
1	Histones (Histone)IBA 03/2017
1	Histone Deacetylase InhibitorsIBA 01/2017
1	hydroxide ionIBA 10/2016
1	Sucralfate (Carafate)FDA LinkGeneric 10/2016
1	AluminumIBA 10/2016
1	Sucrose (Saccharose)IBA 10/2016
1	Sitagliptin Phosphate (Januvia)FDA Link 05/2016
1	orteronelIBA 02/2016
1	Azithromycin (Zithromax)FDA LinkGeneric 10/2013
1	EstersIBA 10/2013
1	Phosphotransferases (Kinase)IBA 07/2011
1	Tolmetin (Tolmetin Sodium)FDA LinkGeneric 01/2010
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2010
1	KetorolacIBA 01/2009
1	Ketorolac Tromethamine (Acular)FDA LinkGeneric 01/2009
1	Clopidogrel (Plavix)FDA Link 01/2009
1	Methotrexate (Mexate)FDA LinkGeneric 10/2007
1	Uranyl NitrateIBA 10/2007
1	Clarithromycin (Biaxin)FDA LinkGeneric 10/2007
1	Etoposide (VP 16)FDA LinkGeneric 10/2007
1	Chlorzoxazone FDA LinkGeneric 10/2007
1	Vancomycin FDA LinkGeneric 10/2007
1	ProdrugsIBA 12/2006
1	SodiumIBA 12/2006
1	SulfonamidesIBA 12/2006
1	CarrageenanIBA 12/2006
1	2- hydroxymethyl- 4- (5- (4- methoxyphenyl)- 3- trifluoromethyl- 1H- 1- pyrazolyl)- 1- benzenesulfonamideIBA 10/2006

Therapy/Procedure

3	Therapeutics 01/2021 - 03/2017
1	Intravenous Infusions 01/2019
1	Castration 01/2018